Botox® after Botox® - a new approach to treat diplopia secondary to cosmetic botulinic toxin use: case reports

Arquivos Brasileiros de Oftalmologia

Cassiano Rodrigues Isaac¹  Maria Regina Catai Chalita²  Luciana D. Pinto¹ 

[1] ,Universidade de BrasíliaBrasília DF ,Brazil

关键词: Botulinum toxins;    type A;    Strabismus;    Diplopia;    Neuromuscular agents;    Humans;    Female;    Adult;    Case reports;    Toxinas botulínicas tipo A;    Estrabismo;    Diplopia;    Fármacos neuromusculares;    Humanos;    Feminino;    Adulto;    Relatos de casos;   

DOI  :  10.1590/S0004-27492012000300014

来源: SciELO

【 摘 要 】

A new technique for the treatment of diplopia secondary to cosmetic botulinum toxin A use is described. In this interventional case reports, two consecutive patients who developed diplopia after periocular cosmetic use of botulinum toxin A were treated with intramuscular botulinum toxin A injection into the antagonist extraocular muscle. Diplopia resolved in both patients in less than 1 week with no side effects or complications. In conclusion, the injection of intramuscular botulinum toxin A is an encouraging option for treatment of diplopia secondary to botulinum toxin A use for facial lifting.

【 授权许可】

CC BY   
 All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License